Renovaro Biosciences Inc. (RENB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.81
-0.01 (-0.75%)
At close: Jan 15, 2025, 1:47 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY12 | FY11 | FY10 |
PE Ratio | -1.86 | -0.8 | -0.89 | -8.77 | -17.09 | -9.3 | -11.54 | -33.77 | -32.41 | -18.66 | -784.8 | -2.06K | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.32K | n/a | n/a | n/a | n/a |
PB Ratio | 1.14 | 0.69 | 1.40 | 1.34 | 1.17 | 0.97 | 0.46 | 47.22 | -88.24 | 12.71 | -575.4 | -4.50K | n/a |
P/FCF Ratio | -13.6 | -2.7 | -6.44 | -11.35 | -18.33 | -18.16 | -16.68 | -61.46 | -38.2 | -21.75 | -980.33 | -2.47K | n/a |
P/OCF Ratio | -13.69 | -2.71 | -6.44 | -11.37 | -18.65 | -19.69 | -16.79 | -61.46 | -38.2 | -21.75 | -980.33 | -2.47K | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -34.42 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.12 | 0.10 | 0.04 | 0.05 | n/a | n/a | 1.36 | -0.16 | 0.03 | -1.24 | -1.99 | n/a |
Quick Ratio | 0.07 | 0.23 | 1.48 | 11.08 | 6.70 | 11.25 | 18.04 | 1.40 | 0.49 | 2.87 | 0.28 | 0.50 | n/a |
Current Ratio | 0.07 | 0.23 | 1.48 | 11.08 | 6.70 | 11.25 | 18.04 | 1.40 | 0.49 | 2.87 | 0.28 | 0.50 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.05 | n/a | n/a | n/a | n/a |
Interest Coverage | -80.73 | -54.54 | -311.33 | -61.65 | -114.34 | -255.58K | -22.6 | -91.41 | -897.18 | -28.73 | -74.63 | n/a | n/a |
Return on Equity (ROE) | -0.61 | -0.85 | -1.56 | -0.15 | -0.07 | -0.1 | -0.04 | -1.4 | 2.72 | -0.68 | 0.73 | 2.19 | n/a |
Return on Assets (ROA) | -0.49 | -0.68 | -1.34 | -0.14 | -0.06 | -0.1 | -0.03 | -0.47 | -1.99 | -0.45 | -1.88 | -2.21 | n/a |
Return on Capital (ROIC) | -0.61 | -0.82 | -1.48 | -0.12 | -0.07 | -0.06 | -0.02 | -1.57 | 3.33 | -0.7 | 0.72 | 2.19 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23.62% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.06K% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.14K% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.96K% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.44K% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.07K% | n/a | n/a | n/a | n/a |